Real-World Use of BTK Inhibitors in Chronic Lymphocytic Leukemia - Episode 4
Marc S. Hoffmann, MD, and Mazyar Shadman, MD, MPH, discuss matching-adjusted indirect comparisons of BTK inhibitors in chronic lymphocytic leukemia.
Related Content: